WallFlex Biliary Post Liver Transplant IDE Pilot

Boston Scientific

Status: Completed

Conditions: Anastomotic Biliary Stricture Post Orthotopic Liver Transplant

Treatments: Device: WallFlex Biliary Fully Covered Stent

Study type: Interventional

Funder types: Industry

Identifiers

NCT01151280

E7055 (Other Identifier)

Details and patient eligibility

About

The primary objective of this study is to demonstrate effectiveness of the WallFlex Biliary RX Fully Covered Stent for anastomotic biliary strictures in post-orthotopic liver transplant (OLT) patients.

Enrollment: 10 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Age 18 or older

2. Post -OLT patients with symptoms of biliary obstruction secondary to anastomotic biliary stricture as assessed by:

   • Clinical signs and symptoms including jaundice, abdominal pain, pruritis, and cholangitis
   • Abnormal liver function tests (serum bilirubin > 1.5 and/or elevated alkaline phosphatase levels)
   • Abnormal imaging on ultrasound, CT scan, or MRCP suggestive of a biliary stricture

3. Willingness and ability to comply with the study procedures and provide written informed consent to participate in the study.

Exclusion criteria

1. Roux-en-Y choledochojejunostomy
2. Suspected nonanastomotic biliary strictures based on imaging(i.e. multiple strictures, strictures that are longer than 8cm in length, strictures located in the intrahepatic ducts and/or in the donor duct proximal to the site of anastomosis)
3. Living donor transplants
4. Transplants performed within 30 days (fresh transplants)
5. Perforation of any duct within the biliary tree
6. Patients with known sensitivity to any components of the stent or delivery system
7. Patients with malignancy involving the biliary tree (including hepatocellular carcinoma)
8. Patients with poor Karnofsky score
9. Life expectancy of less than one year
10. Inability to pass a guidewire through the strictured area
11. Previous biliary metal or multiple plastic stent placement
12. Drug-induced or cholestatic hepatitis from an infective cause
13. Redundant bile duct that may be treated by temporary placement of stent or conversion to a RouxEnY hepaticojejunostomy
14. Choledocholithiasis/biliary "cast" syndrome

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

10 participants in 1 patient group

WallFlex Biliary Fully Covered Stent

Experimental group

Description:

All eligible patients entered into the study will be treated with a WallFlex Biliary Fully Covered Stent

Treatment:

Device: WallFlex Biliary Fully Covered Stent